Artificial intelligence (AI) now…
Artificial intelligence (AI) now features prominently in boardroom and executive [...]
As pharmas like Eli Lilly and…
As pharmas like Eli Lilly and Roche bolster their biotech [...]
Vistagen Therapeutics is doubling…
Vistagen Therapeutics is doubling down on its lead social anxiety [...]
Evotec has escalated its already…
Evotec has escalated its already substantial reorganization, plotting an additional [...]
With a fresh leadership team…
With a fresh leadership team settling in, CNS Pharmaceuticals is [...]
Salspera has set out plans for a…
Salspera has set out plans for a $91 million IPO [...]
Less than a week after Roche…
Less than a week after Roche pledged a hefty investment [...]
Molecular glue-focused biotech f5…
Molecular glue-focused biotech f5 Therapeutics has failed to stick around [...]
The FDA has resumed review of…
The FDA has resumed review of Capricor Therapeutics’ previously rejected [...]
Bristol Myers Squibb’s…
Bristol Myers Squibb’s mezigdomide has scored its first phase 3 [...]